Gaurav Mistry

Gaurav Mistry

Gaurav Mistry

Gaurav Mistry

Partner

1701, One World Centre, Floor 17, Tower 2B, 841, Senapati Bapat Marg, Mumbai – 400013, India

Key Practice Areas

  • Corporate and Securities
  • Media & Entertainment
  • Private Clients

Key Sectors & Industries

  • Education
  • FMCG
  • Healthcare and Pharmaceuticals
  • Manufacturing
  • Hospitality

Education

  • LLB
  • B. Com

Professional Memberships

  • The Bar Council of Maharashtra and Goa
  • Bombay City Civil & Sessions Court Bar Association

Languages

  • English
  • Hindi
  • Gujarati
  • Marathi

Experience

Gaurav is a transaction lawyer has been a part of DSK Legal since 2012 and focuses on corporate and commercial matters such as mergers and acquisitions in the private and public space, strategic alliances and joint ventures involving domestic and international clients, investments by private equity and venture capital investors. He concentrates on corporate laws, foreign investment laws, securities laws, and regularly advises on structuring of commercial transactions and documentation.

Gaurav’s experience is spread across various sectors such as pharmaceuticals, healthcare, education, food and beverages, media and entertainment, logistics, retail, manufacturing, insurance, infrastructure, microfinance, etc. and his areas of practice include:

Advising large multinational and domestic clients on various corporate and commercial matters including structuring, documenting and negotiating complex commercial transactions, more particularly those relating to acquisitions, corporate restructuring, strategic alliances, joint ventures and other similar transactions.

Advising large domestic and foreign private equity funds in various types of transactions viz. minority, control or acquisition transactions and advising them on exits to strategic or other financial investors.

Advice and documentation pertaining to corporate restructuring through mergers, demergers, slump sale and asset sale.

Advising clients in various capital market transactions including initial public offers, offer for sale, qualified institutional placements, open offer, etc.

Rendering general corporate advisory services to clients in connection with a host of corporate laws including company law, securities law, exchange control regulations, takeover regulations, and competition law.

Advised clients in relation to their compliance obligations and risk mitigation under various Indian laws.

Gaurav has publications on diverse subjects to his credit including publications in the Business Standard, Economic Times, MoneyControl and other journals, and websites.

Recent Key Assignments

  • Advised OneSource Specialty Pharma Limited, formerly known as Stelis Biopharma Limited in its pre-listing fundraise of approximately INR 8,010,000,000 at a pre-money equity value of USD 1,650,000,000 (United States Dollars One Billion Six Hundred and Fifty Million) from various marquee investors including domestic and foreign institutional investors, and family offices led by HBM Healthcare Investments and associated investors, with additional participation from White Oak Capital, Param Capital, Motilal Oswal, Enam Holdings and SBI Life Insurance Company Limited.
  • Advised RoomsXML Solutions Private Limited (RSL), and the promoters of RSL in relation to a tranche wise sale of their entire stake in RSL to Go Global Travel Limited. RSL uses a custom-built technology to provide travel agents and other trade customers with the ability to search and book hotels and thus, are engaged in the business of providing travel related services and encompassing the provisions of tools and systems for hotel search and reservations through online platform. RSL has three subsidiaries namely (i) Key Resorts International DMCC in United Arab Emirates; (ii) Websource Pacific Pty Limited in Australia; and (iii) Stuba New Zealand Limited in New Zealand.
  • Advised Stelis Biopharma Limited in relation to sale of business and operations pertaining to Unit III of Stelis, including the Factory and the Solvent Yard, by way of slump sale, to Syngene International Limited, a subsidiary of Biocon Limited, for an aggregate consideration of INR 6,170,000,000/- (Rupees Six Billion and Seventeen Million only).
  • Advised Entropik Technologies Private Limited in relation to raising capital from existing and new investors for an aggregate consideration of approximately USD 25 million, and the sale of shares from existing shareholders to the investors. Entropik is a leading AI-powered integrated market research company, founded in 2016. They enable research, marketing, and product teams to move towards a more continuous, collaborative, agile, and scalable way to capture user feedback by democratizing research and insights data across the organization.
  • Advised erstwhile TPG backed Quality Care India Limited in relation to the acquisition of majority shareholding of United CIIGMA Institute of Medical Sciences Private Limited, along with its other group entities. Also, advised Quality Care India Limited in relation to the acquisition of (i) Convenient Hospitals Limited; (ii) Heartcare Institute & Research Centre (India) Private Limited; (iii) imaging business of Convenient Imaging Solutions, a partnership firm; and (iv) pharmacy business of Central India Pharmacy, a partnership firm.
  • Advised QYOU Media Inc. in relation to the acquisition of 51% (fifty-one percent) shareholding of Maxamtech Digital Ventures Private Limited. QYOU operates as a media company and produces and distributes content created by social media influencers, artists, and digital content creators on television networks, satellite television, over-the-top media, and mobile platforms. QYOU manages influencer marketing campaigns for major film studios and key household brands.

Recent Awards and Recognition

  • In 2023 and 2024 Gaurav has been ranked as a ‘Rising Star Partner’ for M&A by IFLR1000.
  • Gaurav has been ranked as a ‘Next Generation Partner’ for Corporate and M&A by Legal500 Asia-Pacific 2025.
  • In 2023 Gaurav has been ranked as a ‘GENNEXT Leading Lawyer’ for Corporate and M&A by Legal Era.
  • In 2024 Gaurav has been ranked as a ‘Leading Lawyer Champion’ for Pharma and Healthcare by Legal Era.
  • Gaurav has been ranked as ‘Recommended Lawyer’ for Corporate and M&A, Life Sciences and Healthcare, Private Equity and Investment Funds and Capital Market by Legal500 Asia-Pacific 2023.
  • In 2022 Gaurav has been enlisted in the Forbes India Legal Powerlist 2022 as one of the Top 100 Individual Lawyers above 10 years’ experience for – Joint Venture, M&A, PE and VC.
  • Identified as one of ‘India’s Future Legal Leader’ by India Business Law Journal 2022.
  • Awarded ’40 under 40 Rising Star of the Year 2021’ at the Legal Era Awards 2021.